Product Overview & Chemical Description
Boswellia serrata gum resin extract standardized to 65% Boswellic Acids or concentrated 30% AKBA. Potent 5-LOX enzyme inhibitor for bone, joint, and intestinal comfort.
Key Product Advantages & Documentation
Targeted 5-Lipoxygenase (5-LOX) inhibition
Rapid joint comfort & mobility improvement in clinical trials
Zero residual ethylene oxide or toxic solvents
Technical & Pharmacopoeial Specifications
USP / EP Monograph| Botanical Name | Boswellia serrata |
| Plant Part Used | Gum Resin |
| Active Marker % | 65% Boswellic Acids / 30% AKBA |
| Extraction Ratio | 8:1 |
| Assay Testing Method | Titration / HPLC for AKBA |
| Appearance & Texture | Off-White to Creamish Powder |
| Solubility Profile | Dispersible in Alcohol & Oils |
| Heavy Metals Profile | Total Heavy Metals < 10 ppm |
| Microbiological Limits | Complies with EP/USP standards |
| Packaging Standard | 25 kg Drums |
| Shelf Life & Storage | 36 Months • Store in dry place away from heat |
| Minimum Order Quantity (MOQ) | 25 kg |
Formulation Applications
⚡ Joint Mobility & Osteoarthritis Support⚡ Respiratory Health⚡ Anti-aging Topicals
Direct Export Desk
Commercial Quote & Batch COA
Request custom pricing per drum, non-EtO declarations, and sample dispatch to your facility.
✓ Guaranteed Response within 12 Hours
✓ Custom Extraction Ratios Available
✓ NDA & Confidentiality Guaranteed